Ecphora Capital key facts
- Ecphora Capital is a venture capital firm based in Baltimore, Maryland with 10 tracked portfolio companies.
- Notable positions include Longeviti, CoapTech, Nanochon.
- The team roster lists 6 people.
About Ecphora Capital
Founded in 2022, Ecphora Capital is a medtech venture capital firm based in Baltimore, Maryland. The firm seeks to invest in companies operating in the biomedical, medical devices, and biotechnology sectors based in Maryland.
Ecphora Capital portfolio at a glance
Ecphora Capital team
6 people are on record at Ecphora Capital: 3 managing partners, 2 venture partners and 1 partner. Senior names include Deborah Hemingway (Founder), Jeremy Neilson (Managing Director) and Mika Standard (Managing Partner). 6 of them have a verified direct contact on file.
Is this your firm? Sign in with your work email to keep it current, or tell us what's wrong.
- ·The top 10 names in the book — of 10 recorded positions
- ·Watchlist + alerts for Ecphora Capital's activity
Portfolio
10 companies · priced for members| Company | Industry | Valuation | First invested | Role |
|---|---|---|---|---|
| Longeviti | — | ▮ | ▮ | ▮ |
| CoapTech | — | ▮ | ▮ | ▮ |
| Nanochon | — | ▮ | ▮ | ▮ |
+ 7 more companies · all 10, priced and dated or a free account shows the top 10 names — no card Membership and data by Private Market View | ||||
Partners, principals, and the people who answer a pitch. Pro members reveal contacts with credits.
Frequently asked about Ecphora Capital
- What companies does Ecphora Capital invest in?
- Ecphora Capital has 10 recorded portfolio companies, including Longeviti, CoapTech, Nanochon.
- What is Ecphora Capital's AUM?
- Ecphora Capital manages approximately $10.0M in assets.